Synonyms: AMG-073 | Mimpara® | Sensipar®
cinacalcet is an approved drug (EMA & FDA (2004))
Compound class:
Synthetic organic
Comment: Cinacalcet is a positive allosteric activator of the calcium-sensing receptor (CaSR), thus improving the effect of calcium on tissues expressing this receptor.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖View more information in the IUPHAR Pharmacology Education Project: cinacalcet |
|
No information available. |
Summary of Clinical Use |
Used in the treatment of secondary hyperparathyroidism in chronic kidney disease, and for the treatment of hypercalcemia in patients with parathyroid cancer. |
Mechanism Of Action and Pharmacodynamic Effects |
Cinacalcet potentiates the action of extracellular calcium by lowering the threshold for CaSR activation. This effect causes inhibition of PTH secretion and production [6-7]. |